Hutchinson, Samantha A. http://orcid.org/0000-0003-4780-2441
Websdale, Alex
Cioccoloni, Giorgia http://orcid.org/0000-0003-0102-9182
Røberg-Larsen, Hanne
Lianto, Priscilia
Kim, Baek
Rose, Ailsa
Soteriou, Chrysa http://orcid.org/0000-0002-2808-1215
Pramanik, Arindam http://orcid.org/0000-0002-5827-6267
Wastall, Laura M.
Williams, Bethany J. http://orcid.org/0000-0002-6641-5503
Henn, Madeline A.
Chen, Joy J.
Ma, Liqian
Moore, J. Bernadette http://orcid.org/0000-0003-4750-1550
Nelson, Erik http://orcid.org/0000-0002-8887-1905
Hughes, Thomas A. http://orcid.org/0000-0003-1169-3386
Thorne, James L. http://orcid.org/0000-0002-3037-8528
Article History
Received: 6 August 2020
Revised: 15 February 2021
Accepted: 18 February 2021
First Online: 19 March 2021
Compliance with ethical standards
:
: GC was supported by a grant funding from Breast Cancer Action (3T57/9R17–02). The human metabolite data collection and analysis, immunohistochemistry, and antibody validation performed by AW was supported by a grant from Breast Cancer UK (PO-180309) and by the University of Leeds School of Food Science and Nutrition. The British Endocrine Society provided an equipment award (NOV2016) allowing the development of the high throughput chemotherapy efflux assay. SAH, CS, and PL were supported with Leeds Doctoral Scholarships and School of Food Science and Nutrition consumables support. ERN was supported by the National Cancer Institute of the National Institutes of Health (R01CA234025).
: The authors declare no competing interests.